Current Message	Return to posts
From: Hamsterwheel
TRX - worth ten times the current price... http://www.pr?activeinvestors.co.uk/companies/news/108262/tissue-regenix-s-appeal-to-majors-will-grow-as-range-develops-says-broker-108262.html Tissue Regenix (LON:TRX) is potentially worth a significant multiple of its current value to a bidder, house broker Jefferies has suggested. The regenerative med-tech’s speciality is a washing technology that cleans out previous cells and allows human (or animal) tissue be re-used with minimal chance of rejection. Majors need new products to stay relevant to large US hospitals said Jefferies and it would not be a surprise if Tissue Regenix became a takeover target for that reason. “The large medical device companies are grappling with how to move beyond traditional solutions, and TRX is positioned to deliver a neat product that is affordable to bring to market and cost-effective for the payer.” Applying recent takeover valuations it has come up with price in excess of US $1.5bn, or more than 10 times the current share price, in a break-up and take-out scenario. It’s a punchy figure but the broker highlights as well as the skin graft, there are also knee cartilage, heart valves and vascular replacements under development. Operating losses in the year just ended were £8.4mln, reflecting that Tissue is still in its start-up phase but Jefferies expects revenues to start to pick up from now as coverage in the US grows. Dermapure, the wound care skin graft, recently gained Medicare reimbursement recognition in 10.8mln patients across 14 states. Jefferies expects the share price to pick up as coverage of DermaPure broadens further across the US. The company raised £19mln in February, to fund the development of the cartilage and ligament product OrthoPure, as well as the launch preparations in the US. OrthoPure should get a European CE mark in 2016 followed by a launch towards the back-end of the year. Jefferies’ revenues forecasts have been nudged up to US$13mln in 2017 and US$41mln the following year, with 36p the current target price for the shares. Shares today rose 4% to 18.7p.

Messages	Author	Time	Date
TRX - worth ten times the current price......[more]	Hamsterwheel	09:00:42	23/06/2015
>> great stuff if it really takes off ! the demand is there !	Bwana	11:23:01
>> Yes, I might add to my stake.	Hamsterwheel	12:32:01